Cargando…

Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis

BACKGROUND: COMP (Cartilage oligomeric matrix protein) is a matrix protein, which is currently studied as a potential serum marker for cartilage processes in osteoarthritis (OA). The influence of physical exercise on serum COMP is not fully elucidated. The objective of the present study was to monit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersson, Maria LE, Thorstensson, Carina A, Roos, Ewa M, Petersson, Ingemar F, Heinegård, Dick, Saxne, Tore
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712338/ https://www.ncbi.nlm.nih.gov/pubmed/17156423 http://dx.doi.org/10.1186/1471-2474-7-98

Ejemplares similares

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003)

Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
por: Otteby, Kaisa E, et al.
Publicado: (2013)

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
por: Andersson, Maria L E, et al.
Publicado: (2013)

Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
por: Rydell, Emil, et al.
Publicado: (2023)

Proteomic Analysis of Tendon Extracellular Matrix Reveals Disease Stage-specific Fragmentation and Differential Cleavage of COMP (Cartilage Oligomeric Matrix Protein)
por: Dakin, Stephanie Georgina, et al.
Publicado: (2014)

Six-week high-intensity exercise program for middle-aged patients with knee osteoarthritis: a randomized controlled trial [ISRCTN20244858]
por: Thorstensson, Carina A, et al.
Publicado: (2005)

Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
por: Happonen, Kaisa E, et al.
Publicado: (2012)

Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis
por: Tseng, Susan, et al.
Publicado: (2009)

Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions
por: Bond, Andrew R., et al.
Publicado: (2014)

Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity
por: Saghafi, Massoud, et al.
Publicado: (2017)

Incidental Finding of Elevated Serum Cartilage Oligomeric Matrix Protein (sCOMP) in Knee Osteoarthritis Patient with Undiagnosed Colon Cancer: A Case Report
por: Waluyo, Yose, et al.
Publicado: (2021)

Immunolocalization of Collagens (I and III) and Cartilage Oligomeric Matrix Protein in the Normal and Injured Equine Superficial Digital Flexor Tendon
por: Södersten, Fredrik, et al.
Publicado: (2013)

COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis
por: Sandstedt, Joakim, et al.
Publicado: (2021)

Correlation of serum cartilage oligomeric matrix protein with knee osteoarthritis diagnosis: a meta-analysis
por: Bi, Xiaoyang
Publicado: (2018)

Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case–control study
por: Liu, Fengxia, et al.
Publicado: (2016)

Integrin α2β1 Is a Receptor for the Cartilage Matrix Protein Chondroadherin
por: Camper, Lisbet, et al.
Publicado: (1997)

Molecular events in cartilage formation and remodeling
por: Heinegård, Dick
Publicado: (2001)

Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritis
por: Koelling, Sebastian, et al.
Publicado: (2006)

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
por: Joosten, Leo AB, et al.
Publicado: (1999)

Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis
por: Zhang, Junfeng
Publicado: (2018)

Effect of circadian rhythm, age, training and acute lameness on serum concentrations of cartilage oligomeric matrix protein (COMP) neo‐epitope in horses
por: Ekman, S., et al.
Publicado: (2019)

TGF-β Pathways Stratify Colorectal Cancer into Two Subtypes with Distinct Cartilage Oligomeric Matrix Protein (COMP) Expression-Related Characteristics
por: Ding, Jia-Tong, et al.
Publicado: (2022)

Cartilage oligomeric matrix protein in monitoring and prognostication of osteoarthritis and its utility in drug development
por: Das, Bibhu R., et al.
Publicado: (2015)

COMP and TSP-4: Functional Roles in Articular Cartilage and Relevance in Osteoarthritis
por: Maly, Kathrin, et al.
Publicado: (2021)

Cartilage Oligomeric Matrix Protein (COMP)-Mediated Cell Differentiation to Proteolysis Mechanism Networks from Human Normal Adjacent Tissues to Lung Adenocarcinoma
por: Wang, Lin, et al.
Publicado: (2013)

Is knee osteoarthritis a symmetrical disease? Analysis of a 12 year prospective cohort study
por: Metcalfe, Andrew J, et al.
Publicado: (2012)

Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women
por: Kluzek, Stefan, et al.
Publicado: (2015)

Cartilage Oligomeric Matrix Protein–Derived Peptides Secreted by Cartilage Do Not Induce Responses Commonly Observed during Osteoarthritis
por: Andrés Sastre, Enrique, et al.
Publicado: (2020)

Cartilage oligomeric matrix protein in patients with osteoarthritis is independently associated with metastatic disease in prostate cancer
por: Rosas, Samuel, et al.
Publicado: (2019)

Structure, evolution and expression of zebrafish cartilage oligomeric matrix protein (COMP, TSP5). CRISPR-Cas mutants show a dominant phenotype in myosepta
por: Forte-Gomez, Helena Fabiana, et al.
Publicado: (2022)

Identifying the role of ASPN and COMP genes in knee osteoarthritis development
por: Mishra, Abhishek, et al.
Publicado: (2019)

Cartilage oligomeric matrix protein specific antibodies are pathogenic
por: Geng, Hui, et al.
Publicado: (2012)

Cartilage Oligomeric Matrix Protein in Idiopathic Pulmonary Fibrosis
por: Vuga, Louis J., et al.
Publicado: (2013)

Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities
por: Cui, Jiarui, et al.
Publicado: (2022)

Health enhancing physical activity in patients with hip or knee osteoarthritis - an observational intervention study
por: Ernstgård, Anna, et al.
Publicado: (2017)

Correlation of serum cartilage oligometric matrix protein (COMP) and interleukin-16 (IL-16) levels with disease severity in primary knee osteoarthritis: A pilot study in a Malaysian population
por: Das Gupta, Esha, et al.
Publicado: (2017)

Sickness absence in musculoskeletal disorders - patients' experiences of interactions with the Social Insurance Agency and health care. A qualitative study
por: Hubertsson, Jenny, et al.
Publicado: (2011)

Cartilage oligomeric matrix protein enhances the vascularization of acellular nerves
por: Cui, Wei-ling, et al.
Publicado: (2016)

Joint remodeling outcome of serum levels of Dickkopf-1 (DKK1), cartilage oligomeric matrix protein (COMP), and C-telopeptide of type II collagen (CTXII) in rheumatoid arthritis
por: IDRISS, NAGLAA K., et al.
Publicado: (2020)

Altered Synthesis of Cartilage-Specific Proteoglycans by Mutant Human Cartilage Oligomeric Matrix Protein
por: Kwak, Yoon Hae, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8ilbafvsuuqddmtfib178uq3e3